Shenouda Maged (CIK 0001658369)

Latest company ownership

Shares held
788,335
Last filed at
Nov 6, 2025
Confidence Score
89.6
2025Q4
Confidence Score History
2015Q4 2025Q4
Shares held
62,500
Last filed at
Jan 2, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 15, 2025 Dec 16, 2025 RELMADA THERAPEUTICS, INC. CFO Buy 78.8 +11,665 1.48% ✗ $48.1K
Nov 5, 2025 Nov 6, 2025 RELMADA THERAPEUTICS, INC. CFO Buy 100.0 +500,000 173.41% ✗ $1.1M
May 16, 2025 May 20, 2025 RELMADA THERAPEUTICS, INC. CFO Buy 95.0 +200,000 226.41% ✗ $97.2K
Sep 9, 2024 Sep 11, 2024 RELMADA THERAPEUTICS, INC. CFO Buy 95.0 +53,432 153.09% ✗ $149.7K
Jan 29, 2024 Jan 31, 2024 RELMADA THERAPEUTICS, INC. CFO Buy 95.0 +32,675 1466.56% ✗ $125.7K
Mar 8, 2021 Mar 10, 2021 RELMADA THERAPEUTICS, INC. CFO Sell 7.5 -10,000 -81.78% ✓ $354.5K
Feb 24, 2021 Feb 26, 2021 RELMADA THERAPEUTICS, INC. CFO Sell 10.0 -3,000 -57.38% ✓ $102.5K
Feb 11, 2021 Feb 16, 2021 RELMADA THERAPEUTICS, INC. CFO Sell 10.0 -1,428 -39.06% ✓ $50.5K
Feb 8, 2021 Feb 10, 2021 RELMADA THERAPEUTICS, INC. CFO Sell 7.5 -11,372 -83.62% ✓ $399.9K
Feb 2, 2021 Feb 4, 2021 RELMADA THERAPEUTICS, INC. CFO Sell 10.0 -3,200 -58.95% ✓ $112.1K
Jan 27, 2021 Jan 29, 2021 RELMADA THERAPEUTICS, INC. CFO Sell 10.0 -3,000 -57.38% ✓ $95.8K
Jan 22, 2021 Jan 26, 2021 RELMADA THERAPEUTICS, INC. CFO Sell 10.0 -4,000 -64.23% ✓ $141.6K
Oct 21, 2019 Oct 21, 2019 RELMADA THERAPEUTICS, INC. Director Buy 91.3 +978 78.24% ✗ $22.5K
Dec 28, 2018 Jan 2, 2019 Entero Therapeutics, Inc. CFO Buy 91.3 +20,000 47.06% ✗ $26.2K
Dec 15, 2015 Dec 17, 2015 RELMADA THERAPEUTICS, INC. Director Buy 90.0 +3,000 150.00% ✗ $9K
Dec 14, 2015 Dec 16, 2015 RELMADA THERAPEUTICS, INC. Director Buy 90.0 +2,000 100.00% ✗ $5.8K